secwatch.observer — SEC 8-K summary
======================================

Issuer:     ACURA PHARMACEUTICALS, INC (—)
CIK:        0000786947
Form:       8-K
Filed at:   2025-06-24T23:59:59+00:00
Accession:  0001104659-25-061980
Event type: debt
Sentiment:  negative
Materiality: 0.85
Item codes: 1.01, 2.01, 2.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Acura gets $200k more loans from AD Pharma; warns cash may run out by mid-July 2025
--------------------------------------------------------------------------------

- Principal balance on AD Pharma secured note now $8,194,279; accrued interest ~$721k.
- Two new $100k loans received June 3 and June 20, 2025; interest at 5.25% (7.5% default).
- AD Pharma, which owns 65% of Acura's common stock, is the lender; controlled by Mr. Schutte.
- Without additional financing by mid-July 2025, Acura may furlough/lay off employees or seek bankruptcy protection.
- Company states no assurance additional financing will be obtained; proceeds used for day-to-day operations.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/786947/000110465925061980/0001104659-25-061980-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/786947/000110465925061980/tm2518762d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-061980

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer